SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10985647
Source:
http://linkedlifedata.com/resource/pubmed/id/10985647
Search
Subject
(
42
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0041296
,
umls-concept:C0087111
,
umls-concept:C0683312
,
umls-concept:C1555713
pubmed:issue
9
pubmed:dateCreated
2000-12-13
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10985647-10488879
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10985647-10985663
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10985647-9487448
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9706389
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Isoniazid
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1027-3719
pubmed:author
pubmed-author:MathewRR
,
pubmed-author:SanthaTT
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
795
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10985647-Antitubercular Agents
,
pubmed-meshheading:10985647-Drug Resistance
,
pubmed-meshheading:10985647-Drug Therapy, Combination
,
pubmed-meshheading:10985647-Humans
,
pubmed-meshheading:10985647-Isoniazid
,
pubmed-meshheading:10985647-Randomized Controlled Trials as Topic
,
pubmed-meshheading:10985647-Research Design
,
pubmed-meshheading:10985647-Treatment Outcome
,
pubmed-meshheading:10985647-Treatment Refusal
,
pubmed-meshheading:10985647-Tuberculosis
,
pubmed-meshheading:10985647-World Health Organization
pubmed:year
2000
pubmed:articleTitle
The treatment of WHO Category 1 tuberculosis with 2HRZE/6HE is indeed defensible.
pubmed:affiliation
Tuberculosis Research Centre, Chennai, India.
pubmed:publicationType
Journal Article
,
Comment